• EOFlow Completes its First Shipment to Europe

    Sep.30.2021
  • EOFlow Completes its First Shipment to Europe_Fn.pdf (220,738k)
  • ▶ EOFlow’s European exclusive distributing partner Menarini to showcase the EOPatch at EASD 2021

    EOFlow Co., Ltd. (KOSDAQ: 294090) (EOFlow or the Company), a provider of wearable drug delivery solutions, has made its first shipment to Europe today.
     
    After launching the wearable insulin pump in Korea this March and obtaining the CE certification in May, EOFlow is now expanding its reach to Europe, starting with the first shipment completed on September 30.
     
    EOFlow officially launched its EOPatch, Korea’s first (and the world’s second) wearable and disposable insulin pump earlier this year in March.  Key advantages of EOPatch include ▲ 3.5 days’ insulin delivery ▲ App-controlled ▲ Wearable, smart & light ▲ Waterproof ▲Tubeless. The long wear time of 3.5 days allows a twice-a-week replacement cycle, improving the user compliance.
     
    Earlier in 2019, EOFlow signed a 5-year exclusive distribution agreement worth 150 billion Korean Won for the EOPatch with the European pharmaceutical company, Menarini. According to the Company, EOPatch will be sold under Menarini’s diabetes brand name, ‘GlucoMen Day’. In this brand, Menarini handles Blood Glucose Meter (BGM), Continuous Glucose Monitoring (CGM) and the PUMP.
     
    Menarini is holding the launch showcase of its wearable insulin pump at the 57th virtual Annual Meeting of the European Association for the Study of Diabetes (EASD). The EASD 2021 Conference is being held this week from September 27 to October 1 virtually due to the COVID-19.
     
    According to EOFlow’s founder CEO Jesse J. Kim, “Menarini plans to progressively launch the product in Europe from 2022 onwards. EOFlow is also seeking opportunities in other regions with high diabetes incidents such as China and Middle East.”
     
    “This is a remarkable moment for EOFlow to make its first shipment overseas. The Company will accelerate its research and development to expand its portfolio offerings with more value-added products to continue to strengthen our competitiveness.” he added.

    [Photo] Menarini’s Virtual Booth at EASD 2021


    [Photo] GlucoMen Day PUMP


     

We use cookies. By continuing to use our site you accept our cookie policy. Find out more about our privacy policy here

PRIVACY POLICY